Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W S May

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|August 15, 1991
Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferationM P Carroll, J L Spivak, M McMahon, et al.
The Journal of Biological Chemistry|October 28, 1994
Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosisW S May, P G Tyler, T Ito, et al.
Blood|March 15, 1990
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitroR J Jones, S J Sharkis, C B Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cellsW S May, S J Sharkis, A H Esa, et al.
Blood|August 1, 1994
Characterization of murine CD34, a marker for hematopoietic progenitor and stem cellsD S Krause, T Ito, M J Fackler, et al.
Blood|August 15, 1990
The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factorsS J Sharkis, R J Jones, M L Bellis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemiaS M Kornblau, H T Vu, P Ruvolo, et al.
Immunology|November 1, 1992
Four interleukin-2 surface binding proteins detected in rat spleen cellsR K Chopra, M P Carroll, W S May, et al.
Leukemia|April 28, 2006
Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AMLS Kurinna, M Konopleva, S L Palla, et al.
Bone Marrow Transplantation|June 1, 1993
BMT for severe aplastic anemia using cyclosporineW S May, L L Sensenbrenner, W H Burns, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|August 15, 1991
Erythropoietin induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferationM P Carroll, J L Spivak, M McMahon, et al.
The Journal of Biological Chemistry|October 28, 1994
Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosisW S May, P G Tyler, T Ito, et al.
Blood|March 15, 1990
Bryostatin 1, a unique biologic response modifier: anti-leukemic activity in vitroR J Jones, S J Sharkis, C B Miller, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1987
Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cellsW S May, S J Sharkis, A H Esa, et al.
Blood|August 1, 1994
Characterization of murine CD34, a marker for hematopoietic progenitor and stem cellsD S Krause, T Ito, M J Fackler, et al.
Blood|August 15, 1990
The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factorsS J Sharkis, R J Jones, M L Bellis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 25, 2000
BAX and PKCalpha modulate the prognostic impact of BCL2 expression in acute myelogenous leukemiaS M Kornblau, H T Vu, P Ruvolo, et al.
Immunology|November 1, 1992
Four interleukin-2 surface binding proteins detected in rat spleen cellsR K Chopra, M P Carroll, W S May, et al.
Leukemia|April 28, 2006
Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AMLS Kurinna, M Konopleva, S L Palla, et al.
Bone Marrow Transplantation|June 1, 1993
BMT for severe aplastic anemia using cyclosporineW S May, L L Sensenbrenner, W H Burns, et al.
Pageof 8